[Bromazepam in the treatment of anxiety in nephrology and haemodialysis (author's transl)].
Bromazepam was tested in 15 patients with chronic renal failure undergoing haemodialysis and in 10 patients with normal renal function (controls). The initial dosage (6 mg/day) was modified according to anxiolytic response and sedative effects. Satisfactory results were obtained with 6 mg/day in patients under haemodialysis and in controls with reactional anxiety. Relief from anxiety-induced inhibitions and decrease in somatic disorders were observed. The drug was very well tolerated.